Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 25.91
(0.0%)
USD 25.91
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 2.28 Billion NZD | 3.5% |
| 2023 | 2.2 Billion NZD | 4.63% |
| 2022 | 2.1 Billion NZD | 1.54% |
| 2021 | 2.07 Billion NZD | 44.6% |
| 2020 | 1.43 Billion NZD | 18.92% |
| 2019 | 1.2 Billion AUD | 17.72% |
| 2018 | 1.02 Billion AUD | 16.73% |
| 2017 | 878.19 Million AUD | 14.53% |
| 2016 | 766.8 Million AUD | 14.48% |
| 2015 | 669.81 Million AUD | 6.27% |
| 2014 | 630.32 Million AUD | 1.9% |
| 2013 | 618.59 Million AUD | 8.14% |
| 2012 | 572.05 Million AUD | 10.52% |
| 2011 | 517.6 Million AUD | 8.96% |
| 2010 | 475.05 Million AUD | 14.82% |
| 2009 | 413.73 Million AUD | 24.74% |
| 2008 | 331.66 Million AUD | 20.75% |
| 2007 | 274.66 Million AUD | 2.69% |
| 2006 | 267.47 Million AUD | 16.13% |
| 2005 | 230.31 Million AUD | 2.74% |
| 2004 | 224.17 Million AUD | -2.0% |
| 2003 | 228.75 Million AUD | 6.23% |
| 2002 | 215.33 Million AUD | -9.02% |
| 2001 | 236.68 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 2.28 Billion NZD | 3.5% |
| 2024 Q4 | 2.28 Billion NZD | 0.0% |
| 2024 Q2 | 2.38 Billion NZD | 8.51% |
| 2024 Q1 | 2.2 Billion NZD | -0.1% |
| 2023 Q4 | 2.2 Billion NZD | 7.21% |
| 2023 FY | 2.2 Billion NZD | 4.63% |
| 2023 Q1 | 1.89 Billion NZD | -10.08% |
| 2023 Q2 | 2.09 Billion NZD | 10.55% |
| 2023 Q3 | 2.05 Billion NZD | -1.83% |
| 2022 Q4 | 2.1 Billion NZD | 0.0% |
| 2022 FY | 2.1 Billion NZD | 1.54% |
| 2021 Q4 | 2.07 Billion NZD | 0.0% |
| 2021 FY | 2.07 Billion NZD | 44.6% |
| 2020 Q4 | 1.43 Billion NZD | 0.0% |
| 2020 FY | 1.43 Billion NZD | 18.92% |
| 2019 Q4 | 1.2 Billion AUD | 0.0% |
| 2019 FY | 1.2 Billion AUD | 17.72% |
| 2018 FY | 1.02 Billion AUD | 16.73% |
| 2018 Q4 | 1.02 Billion AUD | 0.0% |
| 2017 Q4 | 878.19 Million AUD | 0.0% |
| 2017 FY | 878.19 Million AUD | 14.53% |
| 2016 FY | 766.8 Million AUD | 14.48% |
| 2016 Q4 | 766.8 Million AUD | 0.0% |
| 2015 FY | 669.81 Million AUD | 6.27% |
| 2015 Q4 | 669.81 Million AUD | 0.0% |
| 2014 Q4 | 630.32 Million AUD | 0.0% |
| 2014 FY | 630.32 Million AUD | 1.9% |
| 2013 FY | 618.59 Million AUD | 8.14% |
| 2013 Q4 | 618.59 Million AUD | 0.0% |
| 2012 Q4 | 572.05 Million AUD | 0.0% |
| 2012 FY | 572.05 Million AUD | 10.52% |
| 2011 Q4 | 517.6 Million AUD | 0.0% |
| 2011 FY | 517.6 Million AUD | 8.96% |
| 2010 Q4 | 475.05 Million AUD | 0.0% |
| 2010 FY | 475.05 Million AUD | 14.82% |
| 2009 FY | 413.73 Million AUD | 24.74% |
| 2009 Q4 | 413.73 Million AUD | 0.0% |
| 2008 FY | 331.66 Million AUD | 20.75% |
| 2008 Q4 | 331.66 Million AUD | 0.0% |
| 2007 Q4 | 274.66 Million AUD | 0.0% |
| 2007 FY | 274.66 Million AUD | 2.69% |
| 2006 FY | 267.47 Million AUD | 16.13% |
| 2006 Q4 | 267.47 Million AUD | 0.0% |
| 2005 FY | 230.31 Million AUD | 2.74% |
| 2005 Q4 | 230.31 Million AUD | 0.0% |
| 2004 Q4 | 224.17 Million AUD | 0.0% |
| 2004 FY | 224.17 Million AUD | -2.0% |
| 2003 Q4 | 228.75 Million AUD | 0.0% |
| 2003 FY | 228.75 Million AUD | 6.23% |
| 2002 FY | 215.33 Million AUD | -9.02% |
| 2001 FY | 236.68 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -124036.318% |
| Ansell Limited | 3.23 Billion USD | 29.502% |
| Ansell Limited | 3.24 Billion USD | 29.634% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -366.616% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -759550.022% |
| Psykey, Inc. | 1.72 Million USD | -131991.747% |
| ConvaTec Group Plc | 3.7 Billion USD | 38.473% |
| ConvaTec Group Plc | 3.71 Billion USD | 38.56% |
| Encision Inc. | 3.81 Million USD | -59775.887% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -349917.871% |
| LifePoint, Inc. | 8.8 Million USD | -25801.416% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -14199.95% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -254838.547% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -41468.266% |
| Reflect Scientific, Inc. | 2.66 Million USD | -85392.054% |
| SmileDirectClub, Inc. | 597.06 Million USD | -282.154% |
| Sector 10, Inc. | 1000.00 USD | -228169900.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 51.926% |
| SheerVision, Inc. | 837.56 Thousand USD | -272320.648% |
| United Health Products, Inc. | 284.64 Thousand USD | -801500.601% |
| Vasamed, Inc. | 1.6 Million USD | -142484.595% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -1022290.701% |
| Yubo International Biotech Limited | 2.34 Million USD | -97053.521% |